Does BOTULINUM TOXIN TYPE A Cause Treatment failure? 388 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 388 reports of Treatment failure have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 10.4% of all adverse event reports for BOTULINUM TOXIN TYPE A.
388
Reports of Treatment failure with BOTULINUM TOXIN TYPE A
10.4%
of all BOTULINUM TOXIN TYPE A reports
358
Deaths
292
Hospitalizations
How Dangerous Is Treatment failure From BOTULINUM TOXIN TYPE A?
Of the 388 reports, 358 (92.3%) resulted in death, 292 (75.3%) required hospitalization, and 294 (75.8%) were considered life-threatening.
Is Treatment failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 388 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Treatment failure?
METHOTREXATE (14,672)
ETANERCEPT (11,893)
ADALIMUMAB (9,990)
ABATACEPT (9,301)
RITUXIMAB (9,217)
TOCILIZUMAB (9,097)
HYDROXYCHLOROQUINE (8,786)
LEFLUNOMIDE (8,686)
INFLIXIMAB (8,535)
SULFASALAZINE (7,423)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Treatment failure Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE